- NEWS
Coronavirus vaccines leap through safety trials — but which will work is anybody’s guess
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 583, 669-670 (2020)
doi: https://doi.org/10.1038/d41586-020-02174-y
References
Folegatti, P. M. et al. Lancet https://doi.org/10.1016/S0140-6736(20)31604-4 (2020).
Zhu, F-C. et al. Lancet https://doi.org/10.1016/S0140-6736(20)31605-6 (2020).
Sahin, U. et al. Preprint at MedRxiv https://doi.org/10.1101/2020.07.17.20140533 (2020).
Jackson, L. A. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2022483 (2020).
Grifoni, A. et al. Cell 181, 1489–1501 (2020).